本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sutro Biopharma Inc

0.9816
+0.03063.22%
成交量:69.63万
成交额:70.13万
市值:8,321.43万
市盈率:-0.39
高:1.07
开:0.9700
低:0.9645
收:0.9510
52周最高:4.80
52周最低:0.5231
股本:8,477.42万
流通股本:6,714.98万
量比:1.33
换手率:1.04%
股息:- -
股息率:- -
每股收益(TTM):-2.5119
每股收益(LYR):-2.9606
净资产收益率:-347.64%
总资产收益率:-27.54%
市净率:-2.59
市盈率(LYR):-0.33

数据加载中...

2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/06/25

重要事件披露

Form 8-K - Current report
2025/06/11

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/14

重要事件披露

Form 8-K - Current report
2025/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]